Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Canopy Growth Corp (TSE:WEED – Get Rating) Director David Angelo Lazzarato sold 3,733 shares of the business’s stock in a transaction that occurred on Wednesday, December 28th. The shares were sold at an average price of C$2.97, for a total transaction of C$11,087.01. Following the completion of the transaction, the director now directly owns 14,346 shares of the company’s stock, valued at approximately C$42,607.62.
Canopy Growth Stock Up 1.9 %
WEED stock traded up C$0.06 during midday trading on Monday, hitting C$3.14. 903,762 shares of the company’s stock were exchanged, compared to its average volume of 2,953,657. The stock has a market capitalization of C$1.53 billion and a price-to-earnings ratio of -4.07. The company has a current ratio of 2.84, a quick ratio of 2.32 and a debt-to-equity ratio of 89.09. The firm has a 50 day moving average price of C$4.33 and a 200-day moving average price of C$4.13. Canopy Growth Corp has a 12-month low of C$2.79 and a 12-month high of C$12.18.
Analyst Upgrades and Downgrades
Several equities research analysts have recently issued reports on WEED shares. Jefferies Financial Group raised their price objective on Canopy Growth from C$4.20 to C$4.95 in a report on Friday, November 11th. Benchmark lowered their price target on Canopy Growth to C$3.00 in a report on Wednesday, October 26th. Alliance Global Partners increased their price target on shares of Canopy Growth from C$4.00 to C$4.50 in a research note on Thursday, November 10th. Barclays lowered their price objective on shares of Canopy Growth to C$2.75 and set an “equal weight” rating for the company in a research note on Friday, September 30th. Finally, Sanford C. Bernstein reiterated an “underperform” rating and issued a C$2.00 target price on shares of Canopy Growth in a report on Wednesday, November 9th. Five investment analysts have rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, Canopy Growth has a consensus rating of “Hold” and a consensus target price of C$5.55.
About Canopy Growth
(Get Rating)
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.
Recommended Stories
- MarketBeat: Week in Review 12/26 – 12/30
- The Dogs Of Tech: It’s Time For A Bite Of These Stocks
- Does This Acquisition Make Microsoft a Bear Market Buy?
- Is Kintara Therapeutics A Hidden Gem?
- Should You Warm up to Generac Stock for the Winter?
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Canopy Growth, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Canopy Growth wasn’t on the list.
While Canopy Growth currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Thinking about investing in Meta, Roblox, or Unity? Enter your email below to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
As Featured By:
326 E 8th St #105, Sioux Falls, SD 57103
contact@marketbeat.com
(844) 978-6257
© American Consumer News, LLC dba MarketBeat® 2010-2023. All rights reserved.
© 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart’s disclaimer.
